{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:50:36Z","timestamp":1792792236302,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.amjsurg.2016.10.019","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T01:57:18Z","timestamp":1480471038000},"page":"726-732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The clinical implication of the number of lymph nodes harvested during sentinel lymph node biopsy and its effects on survival outcome in patients with node-negative breast cancer"],"prefix":"10.1016","volume":"214","author":[{"given":"Mi Kyoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5322-6036","authenticated-orcid":false,"given":"Hyung Seok","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee Ye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanggeun","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjsurg.2016.10.019_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.6004\/jnccn.2013.0098","article-title":"Breast cancer, version 3.2013: featured updates to the NCCN guidelines","volume":"11","author":"Theriault","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib4","series-title":"AJCC Cancer Staging Manual","author":"AJCC","year":"2010"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib5","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1245\/s10434-011-1688-1","article-title":"Morbidity of sentinel node biopsy: relationship between number of excised lymph nodes and patient perceptions of lymphedema","volume":"18","author":"Goldberg","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7819-5-18","article-title":"Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery","volume":"5","author":"Povoski","year":"2007","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4048\/jbc.2011.14.4.296","article-title":"How many sentinel lymph nodes are enough for accurate axillary staging in t1-2 breast cancer?","volume":"14","author":"Ban","year":"2011","journal-title":"J\u00a0Breast Cancer"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.breast.2013.03.009","article-title":"A\u00a0nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy","volume":"22","author":"Park","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib10","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3349\/ymj.2016.57.5.1192","article-title":"Comparisons of oncologic outcomes between triple-negative breast cancer (TNBC) and non-TNBC among patients treated with breast-conserving therapy","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4048\/jbc.2011.14.3.191","article-title":"The impact of local and regional recurrence on distant metastasis and survival in patients treated with breast conservation therapy","volume":"14","author":"Lee","year":"2011","journal-title":"J\u00a0Breast Cancer"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5858\/2007-131-18-ASOCCO","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"131","author":"Wolff","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib13","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1245\/s10434-012-2772-x","article-title":"Lack of either estrogen or progesterone receptor expression is associated with poor survival outcome among luminal A breast cancer subtype","volume":"20","author":"Park","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejso.2014.11.004","article-title":"Association of the number of sentinel lymph nodes harvested with survival in breast cancer","volume":"41","author":"Bonneau","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib17","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1072-7515(01)00847-X","article-title":"The breast cancer patient with multiple sentinel nodes: when to stop?","volume":"192","author":"McCarter","year":"2001","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00432-007-0333-7","article-title":"Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine","volume":"134","author":"Kavallaris","year":"2008","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/030089161309900205","article-title":"Sentinel lymph node biopsy in breast cancer: review on various methodological approaches","volume":"99","author":"Zengel","year":"2013","journal-title":"Tumori"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ejca.2008.11.011","article-title":"Effectiveness of immediate preoperative injection of radiopharmaceutical and blue dye for sentinel node biopsy in patients with breast cancer","volume":"45","author":"Dixon","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.gyobfe.2011.07.019","article-title":"[Sentinel lymph node detection in patients with early-stage breast cancer: which site of injection in 2011?]","volume":"39","author":"Frati","year":"2011","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1075-122X.2004.21283.x","article-title":"The optimal number of sentinel lymph nodes for focused pathologic examination","volume":"10","author":"Dabbs","year":"2004","journal-title":"Breast J."},{"key":"10.1016\/j.amjsurg.2016.10.019_bib24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1445-2197.2006.03752.x","article-title":"Optimal number of sentinel nodes after intradermal injection isotope and blue dye","volume":"76","author":"Low","year":"2006","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.amjsurg.2005.10.031","article-title":"Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal?","volume":"191","author":"Woznick","year":"2006","journal-title":"Am J Surg"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.surg.2008.06.005","article-title":"Optimal number of radioactive sentinel lymph nodes to remove for accurate axillary staging of breast cancer","volume":"144","author":"Lynch","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.amjsurg.2016.10.019_bib27","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1245\/s10434-008-9858-5","article-title":"Sentinel nodes in breast cancer: relevance of axillary level II nodes and optimal number of nodes that need to be removed","volume":"15","author":"Boileau","year":"2008","journal-title":"Ann Surg Oncol"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961016309540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961016309540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:11:48Z","timestamp":1757700708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961016309540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0002961016309540"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2016.10.019","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical implication of the number of lymph nodes harvested during sentinel lymph node biopsy and its effects on survival outcome in patients with node-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2016.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}